Skip to main content
. 2022 Feb 2;86(6):1189–1204. doi: 10.1016/j.jaad.2021.11.066

Fig 1.

Fig 1

Outpatient management of skin and soft tissue infections from the Centers for Disease Control and Prevention.

I&D, Incision and drainage; FDA, Food and Drug Administration; MRSA, methicillin-resistant Staphylococcus aureus; SSTI, skin and soft tissue infection.